USA

Products available for everyday use in Eu are often not yet in use in humans even under trial conditions in USA.

“Patient Protection and Affordable Care Act will limit physicians’ clinical decision-making authority in several important ways” according to speakers at Advamed conference

ADVAMED 2011: THE MEDTECH CONFERENCE DAY-TWO FOCUSES ON POLICIES TO PROMOTE LIFE CHANGING INNOVATION AROUND THE WORLD – PRESIDENT GEORGE W. BUSH TO SPEAK

PPACA legislation will demand increased transparency when it comes to payments to clinicians.

C. R. Bard, Inc. senior vice president and chief financial officer, Todd C. Schermerhorn will retire after a transition period that is expected to run until the end of August 2012.

Office based Tennis elbow surgery with Tenex’s new design advanced Tissue Removal System improves ease of use with a total procedure time of less than 15 minutes

Orthofix opened its new North American Operations and Education Center in Lewisville, Texas in August

Baxter International Inc. has announced that FDA has expanded the indication of ARTISS [Fibrin Sealant (Human)] to include adhering tissue flaps during facial rhytidectomy surgery (face-lift)

iphone technology that will change how the fundus is imaged

Sanuwave appoints Executive with Successful Track Record in Wound Care and Medical Devices

Intrinsic Therapeutics, a medical device company focused on developing therapies to address the spine market’s many unmet needs, today announced that Cary Hagan has been appointed President and Chief Executive Officer

Medtronic has won a 100M$+ verdict against Nuvasive for patent infringement in the 14th-largest jury award in the U.S. so far in 2011, according to data compiled by Bloomberg News

Embattled medical device giant Medtronic Inc is feeling the heat again, as reported on www.devicespace.com.  This time it is alleged … continue reading “Spine Surgery Patient Brings Suit Against Medtronic, Inc. (MDT) for “Devastating Side Effects” From off label application of its Infuse Bone Graft Medical Device”

Abiomed, Inc. has announced the first patient enrolled in MINI-AMI, an FDA prospective, randomized, controlled multi-center study to assess the role of 24-hours of direct unloading of the left ventricle with Impella(R) 2.5 support to reduce infarct size in patients with ST-elevation myocardial infarction without cardiogenic shock.

Wall Street Journal has uncovered an unusual contractual arrangement for Michael Mahoney as he returns to Boston Scientific

President Obama is planning a tax levy on US medtech firms who are in turn predicting wide scale job losses. What does this mean for OUS medtech?